MapLight Therapeutics, Inc. (MPLT)
NASDAQ: MPLT · Real-Time Price · USD
6.93
+0.71 (11.41%)
At close: Nov 6, 2026, 4:00 PM EST
7.10
+0.17 (2.45%)
After-hours: Nov 6, 2026, 7:52 PM EST
MapLight Therapeutics Analyst Ratings
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Guggenheim | Guggenheim | Hold Initiates n/a | Hold | Initiates | n/a | n/a | Oct 5, 2026 |
| Needham | Needham | Buy Reiterates $45 → $43 | Buy | Reiterates | $45 → $43 | +520.49% | Aug 31, 2026 |
| Morgan Stanley | Morgan Stanley | Hold Reiterates $21 | Hold | Reiterates | $21 | +203.03% | Aug 17, 2026 |
| LifeSci Capital | LifeSci Capital | Buy Maintains $37 | Buy | Maintains | $37 | +433.91% | Aug 14, 2026 |
| BMO Capital | BMO Capital | Buy Maintains $46 → $20 | Buy | Maintains | $46 → $20 | +188.60% | Aug 14, 2026 |
| UBS | UBS | Hold Downgrades $52 → $13 | Hold | Downgrades | $52 → $13 | +87.59% | Aug 10, 2026 |
Unknown Analyst Jefferies No rating | Jefferies | Buy Maintains $25 | Buy | Maintains | $25 | +260.75% | Jul 30, 2026 |
| Craig-Hallum | Craig-Hallum | Buy Maintains $40 → $25 | Buy | Maintains | $40 → $25 | +260.75% | Jul 28, 2026 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 3 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.